Multiparametric cardiovascular magnetic resonance assessment of cardiac allograft vasculopathy

CA Miller, J Sarma, JH Naish, N Yonan… - Journal of the American …, 2014 - jacc.org
Objectives: This study sought to evaluate the diagnostic performance of multiparametric
cardiovascular magnetic resonance (CMR) for detecting cardiac allograft vasculopathy …

[HTML][HTML] Perfusion cardiac magnetic resonance imaging as a rule-out test for cardiac allograft vasculopathy

S Chih, HJ Ross, AC Alba, CS Fan, C Manlhiot… - American Journal of …, 2016 - Elsevier
Cardiac allograft vasculopathy (CAV) is a leading cause of mortality after heart
transplantation. Noninvasive imaging techniques used in CAV evaluation have important …

Evaluation of cardiac allograft vasculopathy by multidetector computed tomography and whole-heart magnetic resonance coronary angiography

S Nunoda, H Machida, A Sekikawa, K Shitakura… - Circulation …, 2010 - jstage.jst.go.jp
Background: Cardiac allograft vasculopathy (CAV) is a major complication that limits the
long-term survival of recipients of heart transplants. In the present study the feasibility of 2 …

Noninvasive physiologic assessment of cardiac allograft vasculopathy is prognostic for post-transplant events

KJ Clerkin, VK Topkara, MA Farr, R Jain… - Journal of the American …, 2022 - jacc.org
Background Cardiac allograft vasculopathy (CAV) causes impaired blood flow in both
epicardial coronary arteries and the microvasculature. A leading cause of post-transplant …

Myocardial perfusion reserve and strain-encoded CMR for evaluation of cardiac allograft microvasculopathy

C Erbel, N Mukhammadaminova, CA Gleissner… - JACC: Cardiovascular …, 2016 - jacc.org
Objectives: This study sought to evaluate myocardial perfusion reserve index (MPRI) and
diastolic strain rate, both assessed by cardiac magnetic resonance (CMR) as a noninvasive …

Detection and imaging of cardiac allograft vasculopathy

A Pollack, T Nazif, D Mancini, G Weisz - JACC: Cardiovascular Imaging, 2013 - jacc.org
Cardiac allograft vasculopathy (CAV) is an important cause of morbidity and mortality among
cardiac transplant recipients. CAV occurs in approximately 30% of patients by 5 years and …

[HTML][HTML] The challenge to detect heart transplant rejection and transplant vasculopathy non-invasively-a pilot study

E Usta, C Burgstahler, H Aebert, S Schroeder… - Journal of …, 2009 - Springer
Background Cardiac allograft rejection and vasculopathy are the main factors limiting long-
term survival after heart transplantation. In this pilot study we investigated whether non …

CT coronary angiography and dynamic CT myocardial perfusion for detection of cardiac allograft vasculopathy

Y Ahn, HJ Koo, J Hyun, SE Lee, SH Jung, DW Park… - Cardiovascular …, 2023 - jacc.org
Background Cardiac allograft vasculopathy (CAV) is a major obstacle limiting long-term graft
survival. Effective noninvasive surveillance modalities reflecting both coronary artery and …

[HTML][HTML] The role of non-invasive imaging modalities in cardiac allograft vasculopathy: an updated focus on current evidences

C Sciaccaluga, N Ghionzoli, GE Mandoli, N Sisti… - Heart Failure …, 2022 - Springer
Cardiac allograft vasculopathy (CAV) is an obliterative and diffuse form of vasculopathy
affecting almost 50% of patients after 10 years from heart transplant and represents the most …

Reduced myocardial perfusion reserve and transmural perfusiongradient in heart transplant arteriopathyassessed by magnetic resonance imaging

OM Muehling, NM Wilke, P Panse… - Journal of the American …, 2003 - jacc.org
Objectives: The goal of this study was to detect transplant arteriopathy (Tx-CHD) by a
reduced myocardial perfusion reserve (MPR) and resting endomyocardial/epimyocardial …